Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'farnesyltransferase inhibitors' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 161 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Arenz, C; Thutewohl, M; Block, O; Waldmann, H; Altenbach, HJ; Giannis, A
      Manumycin A and its analogues are irreversible inhibitors of neutral sphingomyelinase

      CHEMBIOCHEM
    2. Docampo, R
      Recent developments in the chemotherapy of Chagas' disease

      CURRENT PHARMACEUTICAL DESIGN
    3. Sepp-Lorenzino, L; Tjaden, G; Moasser, MM; Timaul, N; Ma, Z; Kohl, NE; Gibbs, JB; Oliff, A; Rosen, N; Scher, HI
      Farnesyl : protein transferase inhibitors as potential agents for the management of human prostate cancer

      PROSTATE CANCER AND PROSTATIC DISEASES
    4. Johnston, SRD; Kelland, LR
      Farnesyl transferase inhibitors - a novel therapy for breast cancer

      ENDOCRINE-RELATED CANCER
    5. Kelland, LR; Smith, V; Valenti, M; Patterson, L; Clarke, PA; Detre, S; End, D; Howes, AJ; Dowsett, M; Workman, P; Johnston, SRD
      Preclinical antitumor activity and pharmacodynamic studies with the farnesylprotein transferase inhibitor R115777 in human breast cancer

      CLINICAL CANCER RESEARCH
    6. Jones, HA; Hahn, SM; Bernhard, E; McKenna, WG
      Ras inhibitors and radiation therapy

      SEMINARS IN RADIATION ONCOLOGY
    7. Shaikenov, TE; Adekenov, SM; Williams, RM; Prashad, N; Baker, FL; Madden, TL; Newman, R
      Arglabin-DMA, a plant derived sesquiterpene, inhibits farnesyltransferase

      ONCOLOGY REPORTS
    8. Wiesner, J; Wissner, P; Dahse, HM; Jomaa, H; Schlitzer, M
      Discovery of a novel lead structure for anti-malarials

      BIOORGANIC & MEDICINAL CHEMISTRY
    9. Trotter, BW; Quigley, AG; Lumma, WC; Sisko, JT; Walsh, ES; Hamann, CS; Robinson, RG; Bhimnathwala, H; Kolodin, DG; Zheng, W; Buser, CA; Huber, HE; Lobell, RB; Kohl, NE; Williams, TM; Graham, SL; Dinsmore, CJ
      2-Arylindole-3-acetamides: FPP-competitive inhibitors of farnesyl protein transferase

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    10. Crul, M; de Klerk, GJ; Beijnen, JH; Schellens, JHM
      Ras biochemistry and farnesyl transferase inhibitors: a literature survey

      ANTI-CANCER DRUGS
    11. Schwindinger, WF; Robishaw, JD
      Heterotrimeric G-protein beta gamma-dimers in growth and differentiation

      ONCOGENE
    12. Ganguly, AK; Doll, RJ; Girijavallabhan, VM
      Farnesyl protein transferase inhibition: A novel approach to anti-tumor therapy. The discovery and development of SCH 66336

      CURRENT MEDICINAL CHEMISTRY
    13. Gibbs, RA; Zahn, TJ; Sebolt-Leopold, JS
      Non-peptidic prenyltransferase inhibitors: Diverse structural classes and surprising anti-cancer mechanisms

      CURRENT MEDICINAL CHEMISTRY
    14. Xia, Z; Tan, MM; Wong, WWL; Dimitroulakos, J; Minden, MD; Penn, LZ
      Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells

      LEUKEMIA
    15. Eskens, FALM; Awada, A; Cutler, DL; de Jonge, MJA; Luyten, GPM; Faber, MN; Statkevich, P; Sparreboom, A; Verweij, J; Hanauske, AR; Piccart, M
      Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors

      JOURNAL OF CLINICAL ONCOLOGY
    16. Martinelli, G; Tosi, P; Ottaviani, E; Soverini, S; Tura, S
      Molecular therapy for multiple myeloma

      HAEMATOLOGICA
    17. Mitsch, A; Wissner, P; Sattler, I; Schlitzer, M
      Non-thiol farnesyltransferase inhibitors: Structure-activity relationshipsof aralkylsubsituted benzophenones

      ARCHIV DER PHARMAZIE
    18. Brown, JM
      Therapeutic targets in radiotherapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    19. Liu, AX; Rane, N; Liu, JP; Prendergast, GC
      RhoB is dispensable for mouse development, but it modifies susceptibility to tumor formation as well as cell adhesion and growth factor signaling in transformed cells

      MOLECULAR AND CELLULAR BIOLOGY
    20. Pang, YP; Perola, E; Xu, K; Prendergast, FG
      EUDOC: A computer program for identification of drug interaction sites in macromolecules and drug leads from chemical databases

      JOURNAL OF COMPUTATIONAL CHEMISTRY
    21. Germano, D; Pacilio, C; Cancemi, M; Cicatiello, L; Altucci, L; Petrizzi, VB; Sperandio, C; Salzano, S; Michalides, RJAM; Taya, Y; Bresciani, F; Weisz, A
      Inhibition of human breast cancer cell growth by blockade of the mevalonate-protein prenylation pathway is not prevented by overexpression of cyclin D1

      BREAST CANCER RESEARCH AND TREATMENT
    22. Maddala, RL; Reddy, VN; Rao, PV
      Lovastatin-induced cytoskeletal reorganization in lens epithelial cells: Role of rho GTPases

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
    23. Singh, R; Chen, IW; Jin, LX; Silva, MV; Arison, BH; Lin, JH; Wong, BK
      Pharmacokinetics and metabolism of a Ras farnesyl transferase inhibitor inrats and dogs: In vitro-in vivo correlation

      DRUG METABOLISM AND DISPOSITION
    24. Caldelari, D; Sternberg, H; Rodriguez-Concepcion, M; Gruissem, W; Yalovsky, S
      Efficient prenylation by a plant geranylgeranyl-transferase-I requires a functional CaaL box motif and a proximal polybasic domain

      PLANT PHYSIOLOGY
    25. Liu, AX; Cerniglia, GJ; Bernhardt, EJ; Prendergast, GC
      RhoB is required to mediate apoptosis in neoplastically transformed cells after DNA damage

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    26. Huang, CF; Chen, CH; Chuang, NN
      Disrupting the transforming activity of shrimp ras(Q(61)K) by deleting theCAAX box at the C-terminus

      JOURNAL OF EXPERIMENTAL ZOOLOGY
    27. Xu, GP; Pan, JX; Martin, C; Yeung, SCJ
      Angiogenesis inhibition in the in vivo antineoplastic effect of manumycin and paclitaxel against anaplastic thyroid carcinoma

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    28. Pan, JX; Xu, GP; Yeung, SCJ
      Cytochrome c release is upstream to activation of caspase-9, caspase-8, and caspase-3 in the enhanced apoptosis of anaplastic thyroid cancer cells induced by manumycin and paclitaxel

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    29. Fritz, G; Kaina, B
      Ras-related GTPase RhoB represses NF-kappa B signaling

      JOURNAL OF BIOLOGICAL CHEMISTRY
    30. Si, XN; Zeng, Q; Ng, CH; Hong, WJ; Pallen, CJ
      Interaction of farnesylated PRL-2, a protein-tyrosine phosphatase, with the beta-subunit of geranylgeranyltransferase II

      JOURNAL OF BIOLOGICAL CHEMISTRY
    31. Huber, HE; Robinson, RG; Watkins, A; Nahas, DD; Abrams, MT; Buser, CA; Lobell, RB; Patrick, D; Anthony, NJ; Dinsmore, CJ; Graham, SL; Hartman, GD; Lumma, WC; Williams, TM; Heimbrook, DC
      Anions modulate the potency of geranylgeranyl-protein transferase I inhibitors

      JOURNAL OF BIOLOGICAL CHEMISTRY
    32. Hu, YD; Floss, HG
      New type II manumycins produced by Streptomyces nodosus ssp asukaensis andtheir biosynthesis

      JOURNAL OF ANTIBIOTICS
    33. Ashar, HR; James, L; Gray, K; Carr, D; McGuirk, M; Maxwell, E; Black, S; Armstrong, L; Doll, RJ; Taveras, AG; Bishop, WR; Kirschmeier, P
      The farnesyl transferase inhibitor SCH 66336 induces a G(2) -> M or G(1) pause in sensitive human tumor cell lines

      EXPERIMENTAL CELL RESEARCH
    34. Feldkamp, MM; Lau, N; Roncari, L; Guha, A
      Isotype-specific Ras center dot GTP-levels predict the efficacy of farnesyl transferase inhibitors against human astrocytomas regardless of Ras mutational status

      CANCER RESEARCH
    35. End, DW; Smets, G; Todd, AV; Applegate, TL; Fuery, CJ; Angibaud, P; Venet, M; Sanz, G; Poignet, H; Skrzat, S; Devine, A; Wouters, W; Bowden, C
      Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro

      CANCER RESEARCH
    36. Di Paolo, A; Danesi, R; Caputo, S; Macchia, M; Lastella, M; Boggi, U; Mosca, F; Marchetti, A; Del Tacca, M
      Inhibition of protein farnesylation enhances the chemotherapeutic efficacyof the novel geranylgeranyltransferase inhibitor BAL9611 colon cancer cells

      BRITISH JOURNAL OF CANCER
    37. Peters, DG; Hoover, RR; Gerlach, MJ; Koh, EY; Zhang, HY; Choe, K; Kirschmeier, P; Bishop, WR; Daley, GQ
      Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia

      BLOOD
    38. De Vos, ML; Lawrence, DS; Smith, CD
      Cellular pharmacology of cerulenin analogs that inhibit protein palmitoylation

      BIOCHEMICAL PHARMACOLOGY
    39. de Molina, AR; Rodriguez-Gonzalez, A; Penalva, V; Lucas, L; Lacal, JC
      Inhibition of ChoK is an efficient antitumor strategy for Harvey-, Kirsten-, and N-ras-transformed cells

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    40. Adjei, AA
      Blocking oncogenic Ras signaling for cancer therapy

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    41. Song, SY; Meszoely, IM; Coffey, RJ; Pietenpol, JA; Leach, SD
      K-Ras-independent effects of the farnesyl transferase inhibitor L-744,832 on cyclin B1/Cdc2 kinase activity, G2/M cell cycle progression and apoptosis in human pancreatic ductal adenocarcinoma cells

      NEOPLASIA
    42. Sinensky, M
      Recent advances in the study of prenylated proteins

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
    43. Vilella, D; Sanchez, M; Platas, G; Salazar, O; Genilloud, O; Royo, I; Cascales, C; Martin, I; Diez, T; Silverman, KC; Lingham, RB; Singh, SB; Jayasuriya, H; Pelaez, F
      Inhibitors of farnesylation of Ras from a microbial natural products screening program

      JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
    44. Kloog, Y; Cox, AD
      RAS inhibitors: potential for cancer therapeutics

      MOLECULAR MEDICINE TODAY
    45. Honma, Y; Niitsu, N
      Vidarabine and 2-deoxycoformycin as antileukemic agents against monocytic leukemia

      LEUKEMIA & LYMPHOMA
    46. Hill, BT; Perrin, D; Kruczynski, A
      Inhibition of RAS-targeted prenylation: protein farnesyl transferase inhibitors revisited

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    47. Singh, SB; Jayasuriya, H; Silverman, KC; Bonfiglio, CA; Williamson, JM; Lingham, RB
      Efficient syntheses, human and yeast farnesyl-protein transferase inhibitory activities of chaetomellic acids and analogues

      BIOORGANIC & MEDICINAL CHEMISTRY
    48. Adnane, J; Bizouarn, FA; Chen, Z; Ohkanda, J; Hamilton, AD; Munoz-Antonia, T; Sebti, SM
      Inhibition of farnesyltransferase increases TGF beta type II receptor expression and enhances the responsiveness of human cancer cells to TGF beta

      ONCOGENE
    49. Rusyn, EV; Reynolds, ER; Shao, HP; Grana, TM; Chan, TO; Andres, DA; Cox, AD
      Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways

      ONCOGENE
    50. Trempus, CS; Bishop, WR; Njoroge, FG; Boll, RJ; Battalora, MS; Mahler, JG; Haseman, JK; Tennant, RW
      A farnesyl transferase inhibitor suppresses TPA-mediated skin tumor development without altering hyperplasia in the ras transgenic Tg.AC mouse

      MOLECULAR CARCINOGENESIS
    51. Adjei, AA
      Protein farnesyl transferase as a target for the development of anticancerdrugs

      DRUGS OF THE FUTURE
    52. Shi, B; Yaremko, B; Hajian, G; Terracina, G; Bishop, WR; Liu, M; Nielsen, LL
      The farnesyl protein transferase inhibitor SCH66336 synergizes with taxanes in vitro and enhances their antitumor activity in vivo

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    53. Eskens, FALM; Stoter, G; Verweij, J
      Farnesyl transferase inhibitors: current developments and future perspectives

      CANCER TREATMENT REVIEWS
    54. Schlitzer, M; Sattler, I
      Non-thiol farnesyltransferase inhibitors: the concept of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    55. Andrea, H; Fischt, I; Bach, TJ
      Differential interaction of branch-specific inhibitors of isoprenoid biosynthesis with cell cycle progression in tobacco BY-2 cells

      PHYSIOLOGIA PLANTARUM
    56. Baron, R; Fourcade, E; Lajoie-Mazenc, I; Allal, C; Couderc, B; Barbaras, R; Favre, G; Faye, JC; Pradines, A
      RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: Evidenced in vivo by an anti-farnesyl cysteine antibody

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    57. Block, O; Klein, G; Altenbach, HJ; Brauer, DJ
      New stereoselective route to the epoxyquinol core of manumycin-type natural products. synthesis of enantiopure (+)-bromoxone, (-)-LL-C10037 alpha, and (+)-KT 8110

      JOURNAL OF ORGANIC CHEMISTRY
    58. Reuveni, H; Geiger, T; Geiger, B; Levitzki, A
      Reversal of the Ras-induced transformed phenotype by HR12, a novel Ras farnesylation inhibitor, is mediated by the Mek/Erk pathway

      JOURNAL OF CELL BIOLOGY
    59. Zeng, Q; Si, XN; Horstmann, H; Xu, Y; Hong, WJ; Pallen, CJ
      Prenylation-dependent association of protein-tyrosine phosphatases PRL-1,-2, and-3 with the plasma membrane and the early endosome

      JOURNAL OF BIOLOGICAL CHEMISTRY
    60. Chen, Z; Sun, JZ; Pradines, A; Favre, G; Adnane, J; Sebti, SM
      Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice

      JOURNAL OF BIOLOGICAL CHEMISTRY
    61. Yang, WL; Urano, J; Tamanoi, F
      Protein farnesylation is critical for maintaining normal cell morphology and canavanine resistance in Schizosaccharomyces pombe

      JOURNAL OF BIOLOGICAL CHEMISTRY
    62. Adjei, AA; Erlichman, C; Davis, JN; Cutler, DL; Sloan, JA; Marks, RS; Hanson, LJ; Svingen, PA; Atherton, P; Bishop, WR; Kirschmeier, P; Kaufmann, SH
      A Phase I trial of the farnesyl transferase inhibitor SCH66336: Evidence for biological and clinical activity

      CANCER RESEARCH
    63. Yeung, SCJ; Xu, GP; Pan, JX; Christgen, M; Bamiagis, A
      Manumycin enhances the cytotoxic effect of paclitaxel on anaplastic thyroid carcinoma cells

      CANCER RESEARCH
    64. Gatzka, M; Prisco, M; Baserga, R
      Stabilization of the Ras oncoprotein by the insulin-like growth factor 1 receptor during anchorage-independent growth

      CANCER RESEARCH
    65. Omer, CA; Chen, ZX; Diehl, RE; Conner, MW; Chen, HY; Trumbauer, ME; Gopal-Truter, S; Seeburger, G; Bhimnathwala, H; Abrams, MT; Davide, JP; Ellis, MS; Gibbs, JB; Greenberg, I; Hamilton, K; Koblan, KS; Kral, AM; Liu, DM; Lobell, RB; Miller, PJ; Mosser, SD; O'Neill, TJ; Rands, E; Schaber, MD; Senderak, ET; Oliff, A; Kohl, NE
      Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl : protein transferase inhibitor

      CANCER RESEARCH
    66. Di Paolo, A; Danesi, R; Nardini, D; Bocci, G; Innocenti, F; Fogli, S; Barachini, S; Marchetti, A; Bevilacqua, G; Del Tacca, M
      Manumycin inhibits ras signal transduction pathway and induces apoptosis in COLO320-DM human colon tumour cells

      BRITISH JOURNAL OF CANCER
    67. Fritz, G; Kaina, B
      Ras-related GTPase RhoB forces alkylation-induced apoptotic cell death

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    68. Murphy, ST; Bencsik, JR; Johnson, CR
      Enantioselective synthesis of (-)-LL-C10037 alpha from benzoquinone

      ORGANIC LETTERS
    69. Bogusky, MJ; Culberson, JC; Pitzenberger, SM; Garsky, VM; Wallace, A; Pessi, A; Koblan, KS
      Conformation of a novel tetrapeptide inhibitor NH2-D-Trp-D-Met-Phe(pCl)-Gla-NH2 bound to farnesyl-protein transferase

      JOURNAL OF PEPTIDE RESEARCH
    70. Buolamwini, JK
      Novel anticancer drug discovery

      CURRENT OPINION IN CHEMICAL BIOLOGY
    71. Yalovsky, S; Rodriguez-Concepcion, M; Gruissem, W
      Lipid modifications of proteins - slipping in and out of membranes

      TRENDS IN PLANT SCIENCE
    72. Liebermann, F; Korf, BR
      Emerging approaches toward the treatment of neurofibromatoses

      GENETICS IN MEDICINE
    73. Norgaard, P; Law, B; Joseph, H; Page, DL; Shyr, Y; Mays, D; Pietenpol, JA; Kohl, NE; Oliff, A; Coffey, RJ; Poulsen, HS; Moses, HL
      Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis

      CLINICAL CANCER RESEARCH
    74. Dong, DL; Liu, RP; Sherlock, R; Wigler, MH; Nestler, HP
      Molecular forceps from combinatorial libraries prevent the farnesylation of Ras by binding to its carboxyl terminus

      CHEMISTRY & BIOLOGY
    75. Qian, YM; Marugan, JJ; Fossum, RD; Vogt, A; Sebti, SM; Hamilton, AD
      Probing the hydrophobic pocket of farnesyltransferase: Aromatic substitution of CAAX peptidomimetics leads to highly potent inhibitors

      BIOORGANIC & MEDICINAL CHEMISTRY
    76. Schlitzer, M; Sattler, I
      Aromatic carboxylic acids as farnesyl surrogates in farnesylpyrophosphate-based farnesyltransferase inhibitors

      BIOORGANIC & MEDICINAL CHEMISTRY
    77. Ciccarone, TM; MacTough, SC; Williams, TM; Dinsmore, CJ; O'Neill, TJ; Shah, D; Culberson, JC; Koblan, KS; Kohl, NE; Gibbs, JB; Oliff, AI; Graham, SL; Hartman, GD
      Non-thiol 3-aminomethylbenzamide inhibitors of farnesyl-protein transferase

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    78. Donaldson, MJ; Skoumas, V; Watson, M; Ashworth, PA; Ryder, H; Moore, M; Coombes, RC
      XR 3054, structurally related to limonene, is a novel inhibitor of farnesyl protein transferase

      EUROPEAN JOURNAL OF CANCER
    79. Feldkamp, MM; Lau, N; Guha, A
      Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects

      ONCOGENE
    80. Klint, P; Kanda, S; Kloog, Y; Claesson-Welsh, L
      Contribution of Src and Ras pathways in FGF-2 induced endothelial cell differentiation

      ONCOGENE
    81. Weis, B; Giehl, K; Gana-Weisz, M; Egozi, Y; Ben-Baruch, G; Marciano, D; Gierschik, P; Kloog, Y
      A new functional Ras antagonist inhibits human pancreatic tumor growth in nude mice

      ONCOGENE
    82. Tanaka, H; Nishida, K; Sugita, K; Yoshioka, T
      Antitumor efficacy of hypothemycin, a new Ras-signaling inhibitor

      JAPANESE JOURNAL OF CANCER RESEARCH
    83. BOUTIN JA; MARANDE W; PETIT L; LOYNEL A; DESMET C; CANET E; FAUCHERE JL
      INVESTIGATION OF S-FARNESYL TRANSFERASE SUBSTRATE-SPECIFICITY WITH COMBINATORIAL TETRAPEPTIDE LIBRARIES

      Cellular signalling
    84. Beaupre, DM; Kurzrock, R
      RAS and leukemia: From basic mechanisms to gene-directed therapy

      JOURNAL OF CLINICAL ONCOLOGY
    85. Schlitzer, M; Sattler, I; Dahse, HM
      Different amino acid replacements in CAAX-tetrapeptide based peptidomimetic farnesyltransferase inhibitors

      ARCHIV DER PHARMAZIE
    86. Liu, M; Bryant, MS; Chen, JP; Lee, SN; Yaremko, B; Li, ZJ; Dell, J; Lipari, P; Malkowski, M; Prioli, N; Rossman, RR; Korfmacher, WA; Nomeir, AA; Lin, CC; Mallams, AK; Doll, RJ; Catino, JJ; Girijavallabhan, VM; Kirschmeier, P; Bishop, WR
      Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    87. Oliff, A
      Famesyltransferase inhibitors: targeting the molecular basis of cancer

      BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
    88. Girgert, R; Hohnecker, A; Wittrock, J; Schweizer, P
      Inhibition of farnesyl protein-transferase in neuroblastoma cells by alpha-hydroxyfarnesylphosphonate

      ANTICANCER RESEARCH
    89. Fritz, G; Gnad, R; Kaina, B
      Cell and tissue-type specific expression of Ras-related GTPase RhoB

      ANTICANCER RESEARCH
    90. Vidal, M; Endoh, H
      Prospects for drug screening using the reverse two-hybrid system

      TRENDS IN BIOTECHNOLOGY
    91. Macaulay, RJB; Wang, W; Dimitroulakos, J; Becker, LE; Yeger, H
      Lovastatin-induced apoptosis of human medulloblastoma cell lines in vitro

      JOURNAL OF NEURO-ONCOLOGY
    92. Osman, A; Niles, EG; LoVerde, PT
      Characterization of the Ras homologue of Schistosoma mansoni

      MOLECULAR AND BIOCHEMICAL PARASITOLOGY
    93. Bredel, M; Pollak, IF
      The p21-Ras signal transduction pathway and growth regulation in human high-grade gliomas

      BRAIN RESEARCH REVIEWS
    94. Weiss, B; Bollag, G; Shannon, K
      Hyperactive Ras as a therapeutic target in neurofibromatosis type 1

      AMERICAN JOURNAL OF MEDICAL GENETICS
    95. Korf, BR
      Plexiform neurofibromas

      AMERICAN JOURNAL OF MEDICAL GENETICS
    96. Pollack, IF; Bredel, M; Erff, M; Hamilton, AD; Sebti, SM
      Inhibition of Ras and related guanosine triphosphate-dependent proteins asa therapeutic strategy for blocking malignant glioma growth: II - Preclinical studies in a nude mouse model

      NEUROSURGERY
    97. Feldkamp, MM; Angelov, L; Guha, A
      Neurofibromatosis type 1 peripheral nerve tumors: Aberrant activation of the Ras pathway

      SURGICAL NEUROLOGY
    98. Alcaraz, L; Macdonald, G; Ragot, J; Lewis, NJ; Taylor, RJK
      Synthetic approaches to the manumycin A, B and C antibiotics: The first total synthesis of (+)-manumycin A

      TETRAHEDRON
    99. Shiomi, K; Tomoda, H; Otoguro, K; Omura, S
      Meroterpenoids with various biological activities produced by fungi

      PURE AND APPLIED CHEMISTRY
    100. Jansen, B; Schlagbauer-Wadl, H; Kahr, H; Heere-Ress, E; Mayer, BX; Eichler, HG; Pehamberger, H; Gana-Weisz, M; Ben-David, E; Kloog, Y; Wolff, K
      Novel Ras antagonist blocks human melanoma growth

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 20:46:04